Position in QGEN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,894,972
New position
Shares Held
72,302
first reported quarter
Ownership
0.035%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026HRT FINANCIAL LP holds $56,167,229 across 14 Diagnostics & Research names. QGEN ranks #4 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
177,683 | $33,688,696 | |
| 2 | MYGN |
Myriad Genetics Inc
|
1,786,319 | $8,038,435 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
7,571 | $3,635,518 | |
| 4 | QGEN |
Qiagen N.V.
This page
|
72,302 | $2,894,972 | |
| 5 | SHC |
Sotera Health Co
|
139,192 | $1,996,013 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
131,241 | $1,821,625 | |
| 7 | PSNL |
Personalis, Inc.
|
208,891 | $1,330,635 | |
| 8 | VCYT |
Veracyte, Inc.
|
31,312 | $1,008,559 |
All Filings in QGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,894,972 | 72,302 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||